Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14‐ and TNF‐dependent mechanisms

Bacterial endotoxin [lipopolysaccharide (LPS)] stimulates macrophages to sequentially release early [tumor necrosis factor (TNF)] and late [high mobility group box 1 (HMGB1)] proinflammatory cytokines. The requirement of CD14 and mitogen‐activated protein kinases [MAPK; e.g., p38 and extracellular signal‐regulated kinase (ERK)1/2] for endotoxin‐induced TNF production has been demonstrated previously, but little is known about their involvement in endotoxin‐mediated HMGB1 release. Here, we demonstrated that genetic disruption of CD14 expression abrogated LPS‐induced TNF production but only partially attenuated LPS‐induced HMGB1 release in cultures of primary murine peritoneal macrophages. Pharmacological suppression of p38 or ERK1/2 MAPK with specific inhibitors (SB203580, SB202190, U0126, or PD98059) significantly attenuated LPS‐induced TNF production but failed to inhibit LPS‐induced HMGB1 release. Consistently, an endogenous, immunosuppressive molecule, spermine, failed to inhibit LPS‐induced activation of p38 MAPK and yet, still significantly attenuated LPS‐mediated HMGB1 release. Direct suppression of TNF activity with neutralizing antibodies or genetic disruption of TNF expression partially attenuated HMGB1 release from macrophages induced by LPS at lower concentrations (e.g., 10 ng/ml). Taken together, these data suggest that LPS stimulates macrophages to release HMGB1 partly through CD14‐ and TNF‐dependent mechanisms.

[1]  K. Tracey,et al.  Extracellular role of HMGB1 in inflammation and sepsis , 2004, Journal of internal medicine.

[2]  K. Tracey,et al.  Lipid unites disparate syndromes of sepsis , 2004, Nature Medicine.

[3]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Maier,et al.  Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. , 2003, Cytokine.

[5]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[6]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[7]  K. Tracey,et al.  IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1 , 2003, The Journal of Immunology.

[8]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[9]  K. Tracey,et al.  HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.

[10]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[11]  S. Maier,et al.  A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats , 2001, Pain.

[12]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[13]  I. Chaudry,et al.  MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. , 2001, American journal of physiology. Cell physiology.

[14]  S. Goyert,et al.  Induction of TNF-α and MnSOD by endotoxin: role of membrane CD14 and Toll-like receptor-4 , 2001 .

[15]  K. Triantafilou,et al.  A CD14-independent LPS receptor cluster , 2001, Nature Immunology.

[16]  John C. Lee,et al.  SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[17]  K. Moore,et al.  Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages1 , 2000, The Journal of Immunology.

[18]  T. Kodama,et al.  Role of macrophage scavenger receptor in endotoxin shock , 2000, The Journal of pathology.

[19]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[20]  I. Chaudry,et al.  Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin , 2000, Critical care medicine.

[21]  K. Tracey,et al.  Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock , 1999, The Lancet.

[22]  Klaus Resch,et al.  The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism , 1999, The EMBO journal.

[23]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[24]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[25]  K. Tracey,et al.  Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules , 1998 .

[26]  K. Tracey,et al.  Fetuin protects the fetus from TNF , 1997, The Lancet.

[27]  K. Tracey,et al.  Spermine Inhibits Proinflammatory Cytokine Synthesis in Human Mononuclear Cells: A Counterregulatory Mechanism that Restrains the Immune Response , 1997, The Journal of experimental medicine.

[28]  H. Flad,et al.  Lipopolysaccharide‐binding protein mediates CD14‐independent intercalation of lipopolysaccharide into phospholipid membranes , 1996, FEBS letters.

[29]  A. DeFranco,et al.  Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Silver,et al.  Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. , 1996, Immunity.

[31]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[32]  D. Golenbock,et al.  CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide , 1995, The Journal of experimental medicine.

[33]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[34]  S. Goyert,et al.  Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Remick,et al.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. , 1992, Journal of immunology.

[36]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[37]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[38]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[39]  K. Tracey,et al.  CHAPTER 35 – Tumor necrosis factor , 2003 .